Acute myeloid leukemia (AML) is infrequent in patients with human immu
nodeficiency virus (HIV) infection. Among AML, acute promyelocytic leu
kemia (APL) has been rarely described in such patients, with only one
case bring published. We report a 30 years-old intravenous drug abuser
HN-infected male with APL who attained complete clinical, morphologic
al, and molecular remission after differentiation therapy with all-tra
ns-retinoic acid (ATRA) followed by intensive chemotherapy. The result
s of treatment in this patient and in other AML published cases sugges
t that therapy for AML should not be modified because of HIV infection
if patients have an adequate performance status.